| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | CHIEF EXECUTIVE OFFICER, Director | $0 | Apr 3, 2024 | ||
| KROS | Keros Therapeutics, Inc. | Director | May 30, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|